KLRK1 and neoplasm: Even though NKG2D is one of the best characterized primary activating receptors on NK cells, several factors, including tumor microenvironment and genetic variation, impact the efficacy of the NKG2D-mediated antitumor response and, consequently, on the patient ́s clinical outcome.